ALK5-IN-32 (compound EX-09) is a selective ALK-5 inhibitor (10 nM< IC 50<100 nM), inhibits TGF-β -induced SMAD signaling. ALK5-IN-32 has the potential to inhibit growth of tumour in vivo. ALK5-IN-32 can be used in study of proliferative diseases such as cancer, fibrotic diseases, and systemic sclerosis [1].

2785430-88-6

C23H23FN8

430.48

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years